In the past week, CVS stock has gone down by -17.02%, with a monthly decline of -24.95% and a quarterly plunge of -22.74%. The volatility ratio for the week is 3.46%, and the volatility levels for the last 30 days are 2.28% for CVS Health Corp The simple moving average for the last 20 days is -16.83% for CVS stock, with a simple moving average of -22.69% for the last 200 days.
Is It Worth Investing in CVS Health Corp (NYSE: CVS) Right Now?
CVS Health Corp (NYSE: CVS) has a price-to-earnings ratio that is above its average at 9.84x. The stock has a 36-month beta value of 0.54. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 5 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for CVS is 1.25B, and at present, short sellers hold a 1.44% of that float. On May 07, 2024, the average trading volume of CVS was 10.96M shares.
CVS) stock’s latest price update
CVS Health Corp (NYSE: CVS)’s stock price has increased by 0.13 compared to its previous closing price of 55.90. However, the company has seen a -17.02% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-06 that DDD, ASO and CVS have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2024.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with UBS repeating the rating for CVS by listing it as a “Neutral.” The predicted price for CVS in the upcoming period, according to UBS is $60 based on the research report published on May 02, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see CVS reach a price target of $60, previously predicting the price at $87. The rating they have provided for CVS stocks is “Market Perform” according to the report published on May 01st, 2024.
CVS Trading at -23.03% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.77% of loss for the given period.
Volatility was left at 2.28%, however, over the last 30 days, the volatility rate increased by 3.46%, as shares sank -24.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.50% lower at present.
During the last 5 trading sessions, CVS fell by -17.02%, which changed the moving average for the period of 200-days by -25.24% in comparison to the 20-day moving average, which settled at $66.38. In addition, CVS Health Corp saw -29.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Mahoney Michael F, who purchase 9,181 shares at the price of $54.49 back on May 02 ’24. After this action, Mahoney Michael F now owns 9,356 shares of CVS Health Corp, valued at $500,294 using the latest closing price.
LUDWIG EDWARD J, the Director of CVS Health Corp, purchase 1,000 shares at $53.88 during a trade that took place back on May 02 ’24, which means that LUDWIG EDWARD J is holding 21,630 shares at $53,879 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- -0.03 for the gross margin
The net margin for CVS Health Corp stands at 0.02. The total capital return value is set at 0.08. Equity return is now at value 10.07, with 2.99 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 1.11. The interest coverage ratio of the stock is 4.51.
Currently, EBITDA for the company is 19.05 billion with net debt to EBITDA at 4.36. When we switch over and look at the enterprise to sales, we see a ratio of 0.39. The receivables turnover for the company is 11.2for trailing twelve months and the total asset turnover is 1.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
To sum up, CVS Health Corp (CVS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
